Neuronetics (STIM) Capital Expenditures Growth (3y) (2020 - 2026)
Neuronetics (STIM) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 9.52% |
| 10 | Neuronetics | 224.14 Mn | 204.71 Mn | 21.22 Mn | -16.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.02% |
| Mar 31, 2026 | -5.58% |
| Dec 31, 2025 | -24.56% |
| Sep 30, 2025 | -7.26% |
| Jun 30, 2025 | -26.79% |
| Mar 31, 2025 | -65.79% |
| Dec 31, 2024 | -26.57% |
| Sep 30, 2024 | 43.80% |
| Jun 30, 2024 | -26.38% |
| Mar 31, 2024 | 4.13% |
| Dec 31, 2023 | 38.21% |
| Sep 30, 2023 | -46.23% |
| Jun 30, 2023 | 273.93% |
| Mar 31, 2023 | 35.53% |
| Dec 31, 2022 | -13.68% |
| Sep 30, 2022 | 242.94% |
| Jun 30, 2022 | 221.28% |
| Mar 31, 2022 | 190.08% |
| Dec 31, 2021 | 91.76% |
| Sep 30, 2021 | -92.94% |